WARREN, N.J.--(BUSINESS WIRE)--Cordis Corporation today announced the introduction in the United States of the FIRE STAR™ Rx PTCA Dilatation Catheter and the DURA STAR™ Rx PTCA Dilatation Catheter. Both balloons, indicated for expansion in the narrowed area of a coronary artery or bypass graft, will be offered to catheterization laboratories and interventional cardiologists starting on Oct. 15. The U.S. Food and Drug Administration approved the commercialization of these products in late August.